Inflammatix, Inc.

📍 Sunnyvale, United States🗓 Founded 2016👥 97 employees💰 Last funded Sep 2020
Biotechnology Research🌐 inflammatix.com
Website LinkedIn
Inflammatix, Inc., based in Sunnyvale, California, USA, is revolutionizing molecular diagnostics with machine-learning-powered technology to rapidly read a patient’s immune response to improve patient care and reduce major public health burdens. It’s flagship in vitro diagnostic (IVD) test, the TriVerity™ Test System (“TriVerity”) shows the likelihood of a bacterial infection, a viral infection, and illness severity in adult patients with suspected acute infection or sepsis that present to emergency departments. TriVerity empowers physicians to confidently make care decisions, which could influence the selection of antimicrobial therapy, focused workups with judicious laboratory and imaging orders, and patient admission or discharge disposition. TriVerity and future tests are designed to be performed on the company’s proprietary Myrna™ instrument, a cartridge-based benchtop analyzer that is capable of multiplex sample-to-answer quantitation of mRNA in about 30 minutes.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2016
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Inflammatix, Inc.?
Inflammatix, Inc. has 1 investors on record on gritt.io, 1 mid-stage.
When did Inflammatix, Inc. last raise funding?
The most recent investment in Inflammatix, Inc. recorded on gritt.io was in September 2020.
When was Inflammatix, Inc. founded?
Inflammatix, Inc. was founded in 2016.
What industry is Inflammatix, Inc. in?
Inflammatix, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Inflammatix, Inc. based?
Inflammatix, Inc. is headquartered in Sunnyvale, United States.